Interactions between oral antineoplastic agents and concomitant medication: a systematic review
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interactions between oral antineoplastic agents and concomitant medication: a systematic review
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 12, Issue 3, Pages 403-420
Publisher
Informa Healthcare
Online
2013-04-16
DOI
10.1517/14740338.2013.784268
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Concurrent use of proton pump inhibitors or H2 blockers did not adversely affect nilotinib efficacy in patients with chronic myeloid leukemia
- (2012) Ophelia Q. P. Yin et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Renal drug–drug interactions: what we have learned and where we are going
- (2012) Eve-Irene Lepist et al. Expert Opinion on Drug Metabolism & Toxicology
- Drug interaction between lenalidomide and itraconazole
- (2011) Naoto Takahashi et al. AMERICAN JOURNAL OF HEMATOLOGY
- The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer
- (2011) Heather A. Wakelee et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Interaction of sorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: a phase I/II pharmacokinetic interaction study
- (2011) Keith T. Flaherty et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Consensus-Based Evaluation of Clinical Significance and Management of Anticancer Drug Interactions
- (2011) Frank G.A. Jansman et al. CLINICAL THERAPEUTICS
- Renal dysfunction in a renal transplant patient treated concurrently with cyclosporine and imatinib
- (2011) Karen E. Mulder et al. INVESTIGATIONAL NEW DRUGS
- Elevated International Normalized Ratio associated with concomitant warfarin and erlotinib
- (2010) K. S. Thomas et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Concurrent use of tamoxifen with CYP2D6 inhibitors and the risk of breast cancer recurrence
- (2010) Laurent Azoulay et al. BREAST CANCER RESEARCH AND TREATMENT
- Effects of imatinib mesylate on the pharmacokinetics of paracetamol (acetaminophen) in Korean patients with chronic myelogenous leukaemia
- (2010) Dong-Wook Kim et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Phase 1 pharmacokinetic and drug-interaction study of dasatinib in patients with advanced solid tumors
- (2010) Faye M. Johnson et al. CANCER
- A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer
- (2010) Anthony W. Tolcher et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Effects of Nilotinib on Single-Dose Warfarin Pharmacokinetics and Pharmacodynamics
- (2010) Ophelia Q.P. Yin et al. CLINICAL DRUG INVESTIGATION
- In Vitro Cytochrome P450-Mediated Metabolism of Exemestane
- (2010) L. K. Kamdem et al. DRUG METABOLISM AND DISPOSITION
- Pharmacokinetic interaction involving sorafenib and the calcium-channel blocker felodipine in a patient with hepatocellular carcinoma
- (2010) Charline Gomo et al. INVESTIGATIONAL NEW DRUGS
- Effect of the Proton Pump Inhibitor Esomeprazole on the Oral Absorption and Pharmacokinetics of Nilotinib
- (2010) Ophelia Q. P. Yin et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma
- (2010) David A. Reardon et al. JOURNAL OF NEURO-ONCOLOGY
- Pseudotumor cerebri due to the potentiation of all-trans retinoic acid by voriconazole
- (2010) Kelly S. Dixon et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Concomitant use of imatinib and warfarin in chronic phase chronic myeloid leukemia patients does not interfere with drug efficacy
- (2010) Massimo Breccia et al. LEUKEMIA RESEARCH
- Aprepitant for Erlotinib-Induced Pruritus
- (2010) Bruno Vincenzi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Should the concomitant use of erlotinib and acid-reducing agents be avoided? The drug interaction between erlotinib and acid-reducing agents
- (2010) Silvia Duong et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Fatal drug-drug interaction of brivudine and capecitabine
- (2009) Alexandra E. Rätz Bravo et al. ACTA ONCOLOGICA
- Elevated International Normalized Ratio associated with concurrent use of sorafenib and warfarin
- (2009) L. V. Moretti et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Evaluation of Potential Interaction Between Vinorelbine and Clarithromycin
- (2009) Ryoichi Yano et al. ANNALS OF PHARMACOTHERAPY
- Safety of Concomitant Tamoxifen and Warfarin
- (2009) Carrie B Givens et al. ANNALS OF PHARMACOTHERAPY
- Tyrosine kinase inhibitor-induced platelet dysfunction in patients with chronic myeloid leukemia
- (2009) A. Quintas-Cardama et al. BLOOD
- Effects of ketoconazole and carbamazepine on lapatinib pharmacokinetics in healthy subjects
- (2009) Deborah A. Smith et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of a proton pump inhibitor on the pharmacokinetics of imatinib
- (2009) Merrill J. Egorin et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Impact of OATP transporters on pharmacokinetics
- (2009) A Kalliokoski et al. BRITISH JOURNAL OF PHARMACOLOGY
- Electrocardiographic Characterization of the QTc Interval in Patients with Advanced Solid Tumors: Pharmacokinetic- Pharmacodynamic Evaluation of Sunitinib
- (2009) C. L. Bello et al. CLINICAL CANCER RESEARCH
- Sorafenib
- (2009) Gillian M. Keating et al. DRUGS
- Peripheral neuropathy on imatinib treatment for chronic myeloid leukaemia: suspected adverse drug interaction with amlodipine
- (2009) INTERNAL MEDICINE JOURNAL
- Effect of gefitinib on warfarin antithrombotic activity
- (2009) Susumu Arai et al. International Journal of Clinical Oncology
- Colorectal Hepatic Metastases: Adjuvant Chemotherapy and Survival
- (2009) David J. Gallagher et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of the Effect of Gastric Acid pH Modulators on the Bioavailability of Oral Dasatinib in Healthy Subjects
- (2009) Timothy Eley et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Interactions Between Tamoxifen and Antidepressants via Cytochrome P450 2D6
- (2009) Julie Eve Desmarais et al. JOURNAL OF CLINICAL PSYCHIATRY
- Interaction between capecitabine and brivudin in a patient with breast cancer
- (2009) José M. Baena-Cañada et al. Nature Reviews Clinical Oncology
- Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram
- (2008) T L Lash et al. BRITISH JOURNAL OF CANCER
- Effects of imatinib (Glivec) on the pharmacokinetics of metoprolol, a CYP2D6 substrate, in Chinese patients with chronic myelogenous leukaemia
- (2008) Yanfeng Wang et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of antacid on imatinib absorption
- (2008) Brian A. Sparano et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate
- (2008) M. Brave et al. CLINICAL CANCER RESEARCH
- Clinical Implications of CYP2D6 Genotyping in Tamoxifen Treatment for Breast Cancer
- (2008) V. O. Dezentje et al. CLINICAL CANCER RESEARCH
- Rhabdomyolysis Resulting from Pharmacologic Interaction Between Erlotinib and Simvastatin
- (2008) Muthu Veeraputhiran et al. Clinical Lung Cancer
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search